res m glp 1 reviews GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis resbiotic resM GLP-1 (HT) Probiotic

Multiple studies, usually done during endoscopies (EGDs) with or without colonoscopies, have shown that patients on GLP-1 receptor agonists have residual gastric contents when fasting from solids for 8 hours (70% of patients, n=10) and when fasting from solids for up to 16 hours (13.1% after 10 hr, n=84

Importantly, this increased GCG receptor activity did not adversely impact glycemic control

As well as the risks of self-injection, such as accidentally injecting air, there were concerns that peptides could interfere with medicines people -were already taking

Results Twenty-seven participants were randomised to liraglutide ( n = 13) or placebo ( n = 14)